Lupus Erythematosus
Conditions
Brief summary
The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them. The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.
Interventions
OTHERThe Morisky Medication Adherence Scale
The Morisky Medication Adherence Scale will be completed bu the patients
Sponsors
University Hospital, Toulouse
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
Age \>18 years * Patient with systemic lupus erythematosus * Treatment with PLAQUENIL for \> 6 months with dosage of hydroxychloroquinemia planned during the consultation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Non-compliance with hydroxychloroquine treatment | Day 0 | to describe the non-compliance with hydroxychloroquine treatment with the Morisky Medication Adherence Scale |
Countries
France
Outcome results
None listed